Dr. Fernando Torres presented at the Scleroderma Education Day Webinar on February 27, 2021 for the Scleroderma Foundation Texas Bluebonnet Chapter.
His session titled Lung Treatment and Transplant and covered Anti-inflammatory treatment, Anti-fibrosis treatment, and Lung Transplant.
Fernando Torres, MD bio:
- Professor of Medicine at UT Southwestern Medical Center and Director of the Lung Transplant and Pulmonary Hypertension Programs at William P. Clements Jr. University Hospital in Dallas.
- Developed the Pulmonary Hypertension Program, now the largest such program in the United States
- His clinical interests include pulmonary hypertension, lung transplantation, lung volume reduction surgery for emphysema, viral infections in immunosuppressed patients, and clinical outcomes research in lung transplantation and pulmonary hypertension.
- Dr. Torres has served as principal investigator or coinvestigator in many clinical trials, including multicenter clinical trials to improve the survival of lung transplant patients. In addition, he is working on testing new equipment to improve the donor organ supply.
- Texas Monthly named him a Super Doctor in 2018 and he was included in D Magazine's Best Doctors list for 2018. In the same year, Dr. Torres received UT Southwestern's Program Development Award.
Scleroderma Foundation Texas Bluebonnet Chapter
Website: www.scleroderma.org/texas
Email: txchapter@scleroderma.org
Facebook: sclerotxchapter
Twitter: @sclerotxchapter
Instagram: @scleroderma_txchapter